Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BACKGROUND: Mineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. METHODS AND RESULTS: In order to better understand MRA use and subsequent outcomes, we perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Fudim, Marat, Liu, Peter R., Shrader, Peter, Blanco, Rosalia G., Allen, Larry A., Fonarow, Gregg C., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Hylek, Elaine, Go, Alan S., Thomas, Laine, Peterson, Eric D., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015424/
https://www.ncbi.nlm.nih.gov/pubmed/29654203
http://dx.doi.org/10.1161/JAHA.117.007987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015424/
https://www.ncbi.nlm.nih.gov/pubmed/29654203
http://dx.doi.org/10.1161/JAHA.117.007987

Ejemplares similares